Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Processa Pharmaceuticals, Inc. - Common Stock
(NQ:
PCSA
)
0.9389
-0.0181 (-1.89%)
Streaming Delayed Price
Updated: 1:27 PM EST, Dec 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Processa Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 15, 2023
It's time to start breaking down the biggest pre-market stock movers for Thursday as we get ready for another busy day of trading!
Via
InvestorPlace
Over $1M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
June 13, 2023
The Dow Jones closed higher by around 190 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 29, 2023
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Conduct NGC-Cap Trial Based on FDA Guidance and Project Optimus Oncology Initiative
May 18, 2023
Via
Investor Brand Network
Exposures
Product Safety
Earnings Preview: Processa Pharmaceuticals
March 29, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 15, 2023
On Wednesday, 479 stocks made new 52-week lows.
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Report on Gastroparesis Results at Annual Digestive Disease Meeting
April 28, 2023
Via
Investor Brand Network
Exposures
Product Safety
Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
April 14, 2023
The Dow Jones closed higher by around 380 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases FY 2022 Financials, Corporate Update
March 31, 2023
Via
Investor Brand Network
Exposures
Product Safety
Earnings Scheduled For March 30, 2023
March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Schedules Conference Call/Webinar to Review FY 2022 Results, Discuss Corporate Updates
March 23, 2023
Via
Investor Brand Network
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
March 17, 2023
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Doses First Patient in Key Study of Next-Generation Chemotherapy-Capecitabine
March 17, 2023
Via
Investor Brand Network
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's After-Market Session
March 13, 2023
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in Upcoming Oppenheimer Healthcare Conference
March 07, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 23, 2023
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Prioritizes Development of Next Generation Chemotherapies
February 21, 2023
Via
Investor Brand Network
Exposures
Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $6.25M Registered Direct Offering
February 15, 2023
Via
Investor Brand Network
Exposures
Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces $6.25M Registered Direct Offering
February 10, 2023
Via
Investor Brand Network
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 03, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
February 03, 2023
Good morning! It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
February 02, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
January 30, 2023
On Monday, 13 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 25, 2023
On Wednesday, 22 companies hit new 52-week lows.
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Biotech Showcase
January 04, 2023
Via
Investor Brand Network
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Friday
December 30, 2022
Friday's session saw 75 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 29, 2022
On Thursday, 116 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 22, 2022
Thursday's session saw 329 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.